Filters

Etizolam manufacturers

Filters

etizolam

Tablets 0.5 mg, 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs available in
India
Manufacturer #22627

This CTD dossier owner and manufacturer was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

Manufacturer usually replies in 21 days

etizolam + escitalopram

Tablets 0.5 mg + 5 mg, 0.5 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #38861
India-based pharmaceutical formulations company manufacturing Rx generic oral solids, liquids, and semi-solids for domestic and regulated export markets. Dosage forms span infections, metabolic, and cardiovascular therapy areas aligned with Indian and international GMP standards. Committed to quality manufacturing and compliance for multi-market pharmaceutical distribution.

Manufacturer usually replies in 84 days

etizolam + propranolol

Tablets 0.5 mg + 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20027
This company specializes in manufacturing and exporting a diverse range of psychiatric medicines. They have a dedicated team of experts with extensive experience in the field, ensuring the quality and effectiveness of their products. The company focuses on producing prescription drugs in various dosage forms, including tablets, capsules, injectables, syrups, and dry syrups. Their key therapy areas include psychiatry, neurology, and epilepsy. The company boasts a state-of-the-art infrastructure, adhering to WHO GMP standards, and a dedicated in-house testing facility and R&D department, placing them in a competitive position within the industry. With decades of experience in the market, this organization has a strong track record and serves a vast client base across various regions, including North America and the EU.

Manufacturer usually replies in 79 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.